CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Interestingly, IL-1 receptor accessory protein (IL1RAP), which is found to be upregulated in CD34+ and CD34+CD38− CML cells, appears to increase as patients transition from the chronic phase to accelerated and blast crisis phases [43].